Get the Stockscreener App
3.8725
8.90%
-0.3975
Edesa Biotech Inc Stock (EDSA) Forecast
The Edesa Biotech Inc (EDSA) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.3107, representing a +37.14% increase from the current price of $3.8725. The highest analyst price target is $7.4366, and the lowest is $3.1849.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EDSA Price Target
Average 6.4744
(+67.19% Upside)
Is Edesa Biotech Inc (EDSA) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 80.13 | Sell |
| STOCH(9,6) | 81.02 | Sell |
| STOCHRSI(14) | 87.33 | Sell |
| MACD(12,26) | 0.607 | Buy |
| ADX(14) | 50.71 | Buy |
| William %R | -30.33 | Neutral |
| CCI(14) | 183.55 | Buy |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.3199
Buy
|
2.7362
Buy
|
| MA20 |
1.6807
Buy
|
2.1082
Buy
|
| MA50 |
1.5155
Buy
|
1.7244
Buy
|
| MA100 |
1.7225
Buy
|
1.7541
Buy
|
| MA200 |
1.9822
Buy
|
1.9026
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, EDSA could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 3 signaling Sell signals and 1 Neutral signals. This might be a good time to open fresh positions on EDSA, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 80.13 indicates that EDSA is overbought. This suggests that EDSA price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 81.02 indicates that EDSA is oversold. This means that EDSA price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 87.33 indicates that EDSA is oversold. This suggests that EDSA price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 50.71 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 183.55 indicates that EDSA is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term EDSA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Edesa Biotech Inc financial reports and earnings history, Edesa Biotech Inc (EDSA) stock could reach $11.92 by 2030, $3.2368 by 2040 and $4.4276 by 2050. See the projected annual prices until 2050 of the Edesa Biotech Inc stock below:
- Edesa Biotech Inc (EDSA) is expected to reach an average price of $0.5353 in 2035, with a high prediction of $0.9242 and a low estimate of $0.0471. This indicates an $-86.18% rise from the last recorded price of $3.8725.
- Edesa Biotech Inc (EDSA) stock is projected to chart a bullish course in 2040, with an average price target of $3.1401, representing an $-18.91% surge from its current level. The forecast ranges from a conservative $3.2101 to a sky-high $3.2368.
- Our analysts predict Edesa Biotech Inc (EDSA) to jump 25.85% by 2045, soaring from $4.3355 to an average price of $4.8734, potentially reaching $4.7434. While $4.3355 is the low estimate, the potential upside is significant.
- Edesa Biotech Inc (EDSA) stock is expected to climb by 2050, reaching an average of $3.6983, a $-4.50% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.4276 and $4.1759, respectively, highlighting the market's uncertainty.
Edesa Biotech Inc Stock (EDSA) Year by Year Forecast
Edesa Biotech Inc Stock (EDSA) Price Forecast for 2026
The predicted value for Edesa Biotech Inc (EDSA) in 2026 is set at an average of $6.3954. Estimates vary from a peak of $10.40 to a trough of $2.386, indicating an +65.15% surge from the present price of $3.8725.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $5.6422 | $3.1849 | $7.4366 | +45.70% |
| May, 2026 | $3.8396 | $2.7559 | $5.6441 | -0.85% |
| June, 2026 | $4.057 | $3.2514 | $4.6897 | +4.76% |
| July, 2026 | $4.3762 | $3.2907 | $5.5843 | +13.01% |
| August, 2026 | $4.2136 | $3.7236 | $5.1199 | +8.81% |
| September, 2026 | $3.5028 | $3.4328 | $4.7278 | -9.55% |
| October, 2026 | $3.23 | $3.1101 | $3.8165 | -16.59% |
| November, 2026 | $4.2675 | $2.5438 | $4.2675 | +10.20% |
| December, 2026 | $5.7867 | $3.823 | $10.40 | +49.43% |
Edesa Biotech Inc Stock (EDSA) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Edesa Biotech Inc (EDSA) is $3.6947, with a high forecast of $7.3678 and a low forecast of $0.0215. This indicates an -4.59% decrease from the last price of $3.8725.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.1141 | $5.0186 | $7.2641 | +57.89% |
| February, 2027 | $5.0915 | $4.9315 | $7.3678 | +31.48% |
| March, 2027 | $4.1407 | $3.4289 | $5.2232 | +6.93% |
| April, 2027 | $3.6981 | $3.3381 | $4.9324 | -4.50% |
| May, 2027 | $2.6454 | $2.0418 | $3.6912 | -31.69% |
| June, 2027 | $1.6547 | $1.411 | $2.8672 | -57.27% |
| July, 2027 | $1.432 | $0.9966 | $2.4983 | -63.02% |
| August, 2027 | $0.9894 | $0.9694 | $1.6675 | -74.45% |
| September, 2027 | $0.4386 | $0.1786 | $1.0412 | -88.67% |
| October, 2027 | $0.106 | $0.036 | $0.6705 | -97.26% |
| November, 2027 | $0.3634 | $0.0215 | $0.5834 | -90.62% |
| December, 2027 | $0.5626 | $0.0952 | $0.9635 | -85.47% |
Edesa Biotech Inc Stock (EDSA) Price Forecast for 2028
In 2028, Edesa Biotech Inc (EDSA) is projected to reach an average price of $0.6864, with a high projection of $1.3586 and a low estimate of $0.0142. This indicates an -82.27% fall from the last price of $3.8725.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.2699 | $0.2563 | $0.6644 | -93.03% |
| February, 2028 | $0.5614 | $0.1236 | $0.3618 | -85.50% |
| March, 2028 | $0.4435 | $0.4874 | $0.4353 | -88.55% |
| April, 2028 | $0.57 | $0.6016 | $0.5362 | -85.28% |
| May, 2028 | $0.6531 | $0.5563 | $1.1831 | -83.13% |
| June, 2028 | $0.0305 | $0.055 | $1.3586 | -99.21% |
| July, 2028 | $0.00214 | $0.0142 | $0.156 | -99.94% |
| August, 2028 | $0.1829 | $0.0566 | $0.0897 | -95.28% |
| September, 2028 | $0.4762 | $0.4192 | $0.3857 | -87.70% |
| October, 2028 | $0.3582 | $0.3682 | $0.3737 | -90.75% |
| November, 2028 | $0.5145 | $0.5333 | $0.4991 | -86.71% |
| December, 2028 | $0.5907 | $0.5653 | $0.5316 | -84.75% |
Edesa Biotech Inc Stock (EDSA) Price Forecast for 2029
The 2029 price forecast for Edesa Biotech Inc Stock (EDSA) is $3.7493 on average, with a high prediction of $6.9628 and a low estimate of $0.5358. This represents an -3.18% decrease from the previous price of $3.8725.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5724 | $0.5835 | $0.5579 | -85.22% |
| February, 2029 | $0.505 | $0.5645 | $0.4868 | -86.96% |
| March, 2029 | $0.4776 | $0.5442 | $0.5112 | -87.67% |
| April, 2029 | $2.5847 | $0.5358 | $6.9628 | -33.25% |
| May, 2029 | $1.339 | $1.314 | $3.1215 | -65.42% |
| June, 2029 | $2.0963 | $1.1408 | $2.1463 | -45.87% |
| July, 2029 | $3.2237 | $2.0082 | $5.11 | -16.75% |
| August, 2029 | $3.1129 | $2.8907 | $3.8273 | -19.61% |
| September, 2029 | $3.6603 | $3.0848 | $4.6584 | -5.48% |
| October, 2029 | $2.9595 | $2.5595 | $3.8944 | -23.58% |
| November, 2029 | $3.1369 | $2.6113 | $3.6416 | -19.00% |
| December, 2029 | $2.6048 | $2.3648 | $3.5687 | -32.74% |
Edesa Biotech Inc Stock (EDSA) Price Forecast for 2030
Edesa Biotech Inc Stock (EDSA) is expected to reach an average price of $5.9635 in 2030, with a high forecast of $11.92 and a low forecast of $0.0111. This signifies an +54.00% surge from the last price of $3.8725.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.2932 | $0.0832 | $11.92 | -92.43% |
| February, 2030 | $2.498 | $0.0831 | $9.8869 | -35.49% |
| March, 2030 | $1.1027 | $0.7817 | $2.6017 | -71.52% |
| April, 2030 | $0.4074 | $0.2598 | $1.2329 | -89.48% |
| May, 2030 | $2.6149 | $0.0111 | $4.8785 | -32.48% |
| June, 2030 | $2.0706 | $1.227 | $3.7696 | -46.53% |
| July, 2030 | $1.4041 | $1.0292 | $2.0943 | -63.74% |
| August, 2030 | $0.6034 | $0.2618 | $1.6228 | -84.42% |
| September, 2030 | $0.1006 | $0.3512 | $0.9375 | -97.40% |
| October, 2030 | $0.293 | $0.2878 | $0.3222 | -92.43% |
| November, 2030 | $1.6883 | $0.4093 | $0.8284 | -56.40% |
| December, 2030 | $1.4235 | $1.3672 | $1.4533 | -63.24% |
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):